HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Bone sarcoma

Bone sarcoma is a rare and aggressive form of cancer that originates in the bones. This type of cancer primarily affects the bone tissues, often leading to the formation of malignant tumors. Bone sarcomas can occur in any bone in the body but are more commonly found in the long bones, such as the arms and legs. The exact cause of bone sarcoma is not well-understood, and it can develop in individuals of any age. However, it is most frequently diagnosed in children, adolescents, and young adults. There are different subtypes of bone sarcoma, including osteosarcoma, Ewing sarcoma, and chondrosarcoma, each with its unique characteristics and challenges in diagnosis and treatment. Symptoms of bone sarcoma may include persistent bone pain, swelling, and tenderness near the affected area. As the cancer progresses, it may lead to fractures or weakened bones. Diagnosis typically involves a combination of imaging studies, such as X-rays and MRIs, along with a biopsy to confirm the presence of cancerous cells. Treatment options for bone sarcoma often involve a multidisciplinary approach, including surgery, chemotherapy, and radiation therapy. The specific treatment plan depends on factors such as the type and stage of the cancer, as well as the overall health of the patient. Surgical intervention aims to remove the tumor and surrounding tissues, while chemotherapy and radiation therapy target cancer cells that may have spread beyond the primary site. Prognosis for individuals with bone sarcoma varies based on factors like the stage of cancer at diagnosis and the effectiveness of the chosen treatment. Early detection and prompt intervention significantly improve the chances of successful outcomes. Managing the physical and emotional challenges associated with bone sarcoma often involves comprehensive support from healthcare professionals, including oncologists, surgeons, and rehabilitation specialists. Additionally, patients may benefit from psychological support and resources to cope with the impact of cancer on their lives.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp